L-arginine restores dilator responses of the basilar artery to acetylcholine during chronic hypertension

Hypertension

Volumn 27, Issue 4, 1996, Pages 893-896

  Kitazono, Takanari ^a   Faraci, Frank M ^a   Heistad, Donald D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

acetylcholine; arginine; cerebral arteries; endothelium derived factor; nitric oxide; rats, stroke prone SHR

Indexed keywords

ACETYLCHOLINE; ARGININE; ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM;

ANIMAL MODEL; AORTA PRESSURE; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BASILAR ARTERY; BRAIN ARTERY; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME SUBSTRATE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; VASCULAR ENDOTHELIUM;

EID: 0029863328     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.4.893     Document Type: Article

References (26)

1. Mayhan WG, Faraci FM, Heistad DD. Impairment of endothelium-dependent responses of cerebral arterioles in chronic hypertension. Am J Physiol. 1987;253:H1435-H1440.
2. Kitazono T, Heistad DD, Faraci FM. ATP-sensitive potassium channels in basilar artery during chronic hypertension. Hypertension. 1993;22:677-681.
3. Mayhan WG, Faraci FM, Heistad DD. Responses of cerebral arterioles to adenosinc 5′-diphosphate, serotonin, and the thromboxane analogue U-46619 during chronic hypertension. Hypertension. 1988;12:556-561.
4. Mayhan WG. Role of prostaglandin H2-thromboxane A2 in responses of cerebral arterioles during chronic hypertension. Am J Physiol. 1992;262:H539-H543.
5. Kitazono T, Heistad DD, Faraci FM. Enhanced responses of the basilar artery to activation of endothelin B receptors in stroke-prone spontaneously hypertensive rats. Hypertension. 1995;25(part 1): 490-494.
6. Mayhan WG. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. Am J Physiol. 1990;259:H1455-H1462.
7. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation. 1993;87:1475-1481.
8. Luscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, Fla: CRC Press; 1990.
9. Faraci FM, Brian JE. Nitric oxide and the cerebral circulation. Stroke. 1994;25:692-703.
10. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
11. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 1991;338:1546-1550.
12. Rossitch E, Alexander E, Black PM, Cooke JP. L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. J Clin Invest. 1991;87:1295-1299.
13. Creager MA, Gallagher SH, Girerd XJ, Coleman S, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90:1248-1253.
14. Drexler H, Fischell TA, Pinto FJ, Chenzbraun A, Botas J, Cooke JP, Alderman EL. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Circulation. 1994;89:1615-1623.
15. Kuo L, Davis MJ, Cannon MS, Chilian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation: restoration of endothelium-dependent responses by L-arginine. Circ Res. 1992;70:465-476.
16. Luscher TF, Haefeli WE. L-Arginine in the clinical arena: tool or remedy? Circulation. 1993;87:1746-1748.
17. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
18. Faraci FM, Heistad DD, Mayhan WG. Role of large arteries in regulation of blood flow to brain stem in cats. J Physiol (Land). 1987;387:115-123.
19. Yang S-T, Mayhan WG, Faraci FM, Heistad DD. Endothelium-dependent responses of cerebral blood vessels during chronic hypertension. Hypertension. 1991;17:612-618.
20. Hasegawa T, Takagi S, Nishimaki K, Morita K, Nakajima S. Impairment of L-arginine metabolism in spontaneously hypertensive rats. Biochem Int. 1992;26:653-658.
21. Lee L, Webb RC. Endothelium-dependent relaxation and L-arginine metabolism in genetic hypertension. Hypertension. 1992;19:435-441.
22. G-nitro-L-arginine methyl ester. J Hypertens. 1991;9:S192-S193.
23. Faraci FM, Brian JE, Heistad DD. Responses of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol. 1995;269:H1522-H1527.
24. Izuta M, Clavier N, Kirsch JR, Traystman RJ. Cerebral blood flow during inhibition of brain nitric oxide synthase activity in normal, hypertensive, and stroke-prone (SHR-SP) rats. Stroke. 1995;26:1079-1085.
25. Mayhan WG, Didion SP, Patel KP. L-arginine does not restore endothelium-dependent dilatation of the basilar artery during diabetes mellitus. J Cereb Blood Flow Metab. In press.
26. Assreuy J, Cunha FQ, Liew FY, Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharamcol. 1993;108:833-837.